MUC16 and ovarian cancer: Expression of CA125 in mucinous, endometroid and other less common subtypes of OC was found to be lower than expression levels seen in serous carcinomas [49,50], further highlighting its inadequacy as a standalone biomarker for ovarian cancer diagnosis.